Highlights and Quick Summary
- Depreciation & Amortization for the quarter ending February 28, 2022 was $4.75 Million (a 0.22% increase compared to previous quarter)
- Year-over-year quarterly Depreciation & Amortization increased by 3.44%
- Annual Depreciation & Amortization for 2021 was $24.6 Million (a 79.67% increase from previous year)
- Annual Depreciation & Amortization for 2020 was $13.7 Million (a 104.81% increase from previous year)
- Annual Depreciation & Amortization for 2019 was $6.69 Million (a 146.63% increase from previous year)
- Twelve month Depreciation & Amortization ending February 28, 2022 was $26 Million (a 2.44% increase compared to previous quarter)
- Twelve month trailing Depreciation & Amortization increased by 52.63% year-over-year
Trailing Depreciation & Amortization for the last four month:
| 28 Feb '22 | 30 Nov '21 | 31 Aug '21 | 31 May '21 |
|---|---|---|---|
| $26 Million | $25.4 Million | $24.6 Million | $17 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Depreciation & Amortization of Organigram Holdings Inc.
Most recent Depreciation & Amortizationof OGI including historical data for past 10 years.Interactive Chart of Depreciation & Amortization of Organigram Holdings Inc.
Organigram Holdings Inc. Depreciation & Amortization for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $4.75 | – | – | – | – |
| 2021 | $4.74 | $11.9 | $4.59 | $4.13 | $24.63 |
| 2020 | $4.0 | $4.3 | $3.23 | $3.28 | $13.71 |
| 2019 | $2.54 | $2.47 | $1.62 | $1.33 | $6.69 |
| 2018 | – | – | $1.29 | $7.38 | $2.71 |
| 2017 | – | – | – | – | $1.23 |
| 2016 | – | – | – | – | $0.6 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic